KLCM
ABBV icon

KG&L Capital Management’s AbbVie ABBV Stock Holding History

KG&L Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,045
Closed -$239K – 124
2025
Q4 		$239K Sell
1,045
-20
-2% -$4.56K 0.06% 198
2025
Q3 		$247K Buy
+1,065
New +$217K 0.07% 191
2025
Q2 		– Sell
-1,164
Closed -$244K – 188
2025
Q1 		$244K Sell
1,164
-143
-11% -$27.8K 0.08% 172
2024
Q4 		$232K Sell
1,307
-647
-33% -$119K 0.07% 169
2024
Q3 		$386K Sell
1,954
-20
-1% -$3.73K 0.12% 144
2024
Q2 		$339K Sell
1,974
-456
-19% -$75.5K 0.12% 149
2024
Q1 		$443K Sell
2,430
-3,795
-61% -$654K 0.18% 125
2023
Q4 		$965K Buy
6,225
+1,319
+27% +$192K 0.4% 55
2023
Q3 		$731K Sell
4,906
-762
-13% -$112K 0.35% 60
2023
Q2 		$764K Sell
5,668
-548
-9% -$80.4K 0.37% 59
2023
Q1 		$991K Buy
6,216
+4,314
+227% +$660K 0.52% 45
2022
Q4 		$307K Sell
1,902
-1,210
-39% -$186K 0.18% 101
2022
Q3 		$418K Buy
+3,112
New +$447K 0.24% 86

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

KG&L Capital Management's ABBV Position: Q1 2026 in Review

KG&L Capital Management sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 1,045 shares — an estimated $239K sold.

KG&L Capital Management first reported a position in ABBV in Q3 2022 and held it in 13 quarters. The position peaked at $991K in Q1 2023. 4,097 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • KG&L Capital Management reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • KG&L Capital Management sold 1,045 AbbVie shares in Q1 2026, an estimated $239K.
  • KG&L Capital Management first reported a position in AbbVie in Q3 2022 and held it in 13 quarters.
  • KG&L Capital Management's AbbVie position peaked at $991K in Q1 2023.
  • 4,097 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on KG&L Capital Management's 13F filing for Q1 2026, filed 23 Apr 2026.